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Purpose: Acute side effects of radiation such as oral mucositis are observed in 
most patients. Although several potential radioprotective agents have been pro-
posed, no effective agent has yet been identified. In this study, we investigated the 
effectiveness of synthetic compound 3-amino-3-(4-fluoro-phenyl)-1H-quinoline-
2,4-dione (KR22332) as a radioprotective agent. Materials and Methods: Cell vi-
ability, apoptosis, the generation of reactive oxygen species (ROS), mitochondrial 
membrane potential changes, and changes in apoptosis-related signaling were ex-
amined in human keratinocyte (HaCaT). Results: KR22332 inhibited irradiation-
induced apoptosis and intracellular ROS generation, and it markedly attenuated 
the changes in mitochondrial membrane potential in primary human keratinocytes. 
Moreover, KR22332 significantly reduced the protein expression levels of ataxia 
telangiectasia mutated protein, p53, and tumor necrosis factor (TNF)-α compared 
to significant increases observed after radiation treatment. Conclusion: KR22332 
significantly inhibited radiation-induced apoptosis in human keratinocytes in vitro, 
indicating that it might be a safe and effective treatment for the prevention of radi-
ation-induced mucositis.
Key Words:   Radiation induced oral mucositis, 3-amino-3-(4-fluoro-phenyl)-1H-
quinoline-2,4-dione (KR22332), apoptosis, radioprotection
INTRODUCTION
Radiation is an effective treatment modality that is commonly used to treat a vari-
ety of solid cancers. Despite many technical advances such as intensity modula-
tion or tomotherapy, oral mucositis (OM) remains one of the most common and 
troubling side effects of radiation therapy. OM is especially prevalent in patients 
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ation-induced OM: the novel synthetic compound 3-amino-
3-(4-fluoro-phenyl)-1H-quinoline-2,4-dione (KR22332). 
KR22332 was developed initially as a neuroprotective agent 
for ischemic stroke, epilepsy, and damage from chemical 
weapons such as organophosporus. It was found to exhibit 
antioxidant properties, and we showed previously that 
KR22332 exerts an otoprotective effect by preventing cispla-
tin-induced ototoxicity through the inhibition of reactive oxy-
gen species (ROS) generation.5 Based on these findings, we 
felt that KR22332 could be a promising candidate protective 
agent against radiation-induced toxicity. In the present study, 
we evaluated the effectiveness of KR22332 as a protective 
agent against radiation-induced cellular toxicity in vitro.
MATERIALS AND METHODS
　　　
Synthesis and preparation of KR22332
KR22332 was synthesized as described previously in five re-
action steps using the commercially available starting materi-
al 2-amino-6-benzoic acid methyl ester (Fig. 1).5 The struc-
ture of KR22332 was identified by 1H nuclear magnetic reso-
nance (NMR) spectroscopy: 1H NMR (300 MHz, CDCl3) δ 
undergoing treatment for head and neck cancers, in which 
the oral cavity and oropharynx are included in the irradia-
tion field.1 The vast majority of patients who receive cumu-
lative radiation doses of more than 30 Gy to the oral muco-
sal field will develop this condition.2 The frequency of 
severe OM exceeds 90% in patients treated for cancers of 
the oral cavity and oropharynx.3 OM causes pain, dry mouth, 
and decreased appetite in patients, resulting in a decreased 
quality of life. OM affects treatment delivery and is often a 
dose-limiting factor that increases the morbidity, mortality, 
and cost of treatment.3 Despite various attempts to prevent 
and treat radiation-induced mucositis, no intervention mo-
dality has yet been identified that completely relieves OM.
The pathobiology of radiation-induced OM includes the 
release of free radicals, modified proteins, and proinflam-
matory cytokines such as interleukin-1β, prostaglandins, 
and tumor necrosis factor (TNF) by epithelial, endothelial, 
and connective tissue cells.4 These mediators cause further 
injury either directly or indirectly to the oral mucosa. There-
fore, we sought a new antioxidant that could be helpful in 
preventing mucosal damage during the initial stages of ra-
diation-induced OM. 
We identified a candidate compound for preventing radi-
Fig. 1. Structure of 3-amino-3-(4-fluoro-phenyl)-1H-quinoline-2,4-dione (KR22332).
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KR22332 (10 μg/mL) for 24 h. The stained cells were ana-
lyzed under a fluorescence microscope (400×; Carl Zeiss, 
Oberkochen, Germany); the number of TUNEL-positive 
cells was determined in triplicate.
Annexin V-fluorescein isothiocynate (FITC)/propidium 
iodide (PI) double staining
A quantitative analysis of apoptotic cell death caused by radi-
ation was performed using a FITC Annexin V Apoptosis De-
tection kit II (Becton Dickinson, Franklin Lakes, NJ, USA). 
Cells were stained using an Annexin V-FITC apoptosis de-
tection kit, following the manufacturer’s protocol. Briefly, 
HaCaT cells were plated at 3×105 cells/well in a 6-well plate, 
incubated for 24 h, and then treated with KR22332 (10 μg/
mL) only, radiation only (8 Gy), or radiation (8 Gy) plus 
KR22332 (10 μg/mL) for 72 h. The cells were then harvest-
ed, washed with cold PBS, and subjected to Annexin V-FITC 
and PI staining in binding buffer at room temperature for 10 
min in the dark. The stained cells were analyzed by fluores-
cence-activated cell sorting (FACS ARIA3; BD Biosciences, 
San Jose, CA, USA) using WinMDI 2.9 software.
Mitochondrial membrane potential (MMP) assay
The MMP of intact cells was measured by flow cytometry 
with the lipophilic cationic probe 5,5 V,6,6 V-tetrachlo-
ro-1,1 V 3,3 V-tetra ethylbenzimidazol-carbocyanine iodide 
(JC-1; Molecular Probes, Eugene, OR, USA). Briefly, the 
culture medium was removed from adherent HaCaT cells, 
and the cells were rinsed with PBS. The cell monolayers 
were then incubated with DMEM and 5 mg/mL JC-1 at 
33°C for 20 min. The cells were subsequently washed twice 
with cold PBS, trypsinized, and then treated with KR22332 
(5 or 10 μg/mL) only, radiation only (8 Gy), or radiation (8 
Gy) plus KR22332 (5 or 10 μg/mL) for 24 h. The pelleted 
cells were then resuspended in 500 μL of PBS. The change 
in MMP was measured by flow cytometry.
 
Measurement of intracellular ROS generation
Intracellular generation of ROS was quantified using 5-(and 
6)-carboxyl-20,70-dichlorodihydro fluorescein diacetate 
(DCFDA; Molecular Probes). For the assay, HaCaT cells 
were cultured overnight on 6-well plates and then exposed 
to radiation (8 Gy) in the presence or absence of KR22332 
(10 μg/mL). After radiation, the cells were incubated for 24 
h and then treated with 10 μM DCFDA in serum-free medi-
um for 10 min at 33°C in the dark. The oxidative burst (hy-
drogen peroxide) was detected using a FACScan flow cy-
2.50 (br s, 2H, NH2), 6.76--6.80 (m, 2H, ArH), 6.95--7.01 
(m, 2H, ArH), 7.36--7.44 (m, 3H, ArH), 9.87 (s, 1H, NH). 
The powdered KR22332 was prepared as solution with vari-
ous concentrations using dimethyl sulfoxide (DMSO) (Santa 
Cruz Biotechnology, Dallas, TX, USA) as a solvent.
Cell culture
Human keratinocyte (HaCaT) cells were obtained from the 
American Type Culture Collection (Manassas, VA, USA), 
and the human head and neck squamous cell carcinoma 
(HNSCC) cell line HN3 was derived from patients with 
HNSCC. The cells were grown in high glucose Dulbecco’s 
modified Eagle’s medium (DMEM; Gibco, Grand Island, 
NY, USA) containing 10% fetal bovine serum (Gibco) and 
penicillin (50 U/mL) in a humidified atmosphere contain-
ing 5% CO2.
Irradiation
A single dose of radiation was delivered by opposed photon 
beams at a distance of 100 cm from the source to the axis 
using a 6 MV linear accelerator system (21EX Linear Ac-
celerator; Varian Co., Palo Alto, CA, USA) as described 
previously.6
Cell viability assay
To determine cell viability, HaCaT and HN3 cells were 
seeded in 96-well plates at a density of 2×103 cells/well in 1 
mL of complete medium after treatment with various con-
centrations of KR22322 (0--50 μg/mL) and various doses of 
radiation (0--20 Gy) or radiation plus KR22322. At 72 h af-
ter treatment, 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyl-
2H-tetrazolium bromide (MTT; Sigma Chemical Co., St. 
Louis, MO, USA) was added to 40 μL of the cell suspen-
sion for 4 h. After three washes with phosphate-buffered sa-
line (PBS; pH 7.4), the insoluble formazan product was dis-
solved in dimethyl sulfoxide. The optical density of each 
culture well was measured using a microplate reader (Bio-
Tek, Winooski, VT, USA) at 560 nm.
Terminal deoxynucleotidyl transferase (TdT)-mediated 
dUTP-biotin nick end labeling (TUNEL) assay
HaCaT cell apoptosis was determined by the TUNEL 
method using an in situ cell detection kit (Roche Molecular 
Biochemicals, Mannheim, Germany) according to the man-
ufacturer’s instructions. The cells, prepared as described 
previously,5 were exposed to medium with KR22332 (10 
μg/mL) only, radiation only (8 Gy), or radiation (8 Gy) plus 
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(Fig. 2B). Irradiated HaCaT cells treated with various con-
centrations of KR22332 (0, 1, 10, and 50 μg/mL) were sig-
nificantly protected from radiation-induced cytotoxicity in a 
dose-dependent manner (Fig. 2C). The slight decrease in 
cell viability observed in the 50 μg/mL KR22332-treated 
group might be due to a cytotoxic effect of the high dose of 
KR22332 (Fig. 2B). HaCaT cells displayed optimal viabili-
ty at 10 μg/mL of KR22332 after irradiation (8 Gy). There-
fore, the remaining experiments were performed using 10 
μg/mL of KR22332 and 8 Gy of irradiation.
KR22332 does not decrease the therapeutic effect of 
radiation against cancer cells
If KR22332 decreases the effect of anti-cancer treatment, 
KR22332 might not be applied in clinical setting in spite of 
protective property on radiation induced mucosal damage. 
Therefore, we investigated the effect of KR22332 on the 
therapeutic effect of radiation against cancer cells derived 
from HNSCC. Interestingly, differing from the normal ke-
ratinocyte HaCaT cells (Fig. 2B), KR22332 alone showed 
decrease of cancer cell viability (Fig. 3A). As shown in Fig. 
3B, irradiation significantly decreased the viability of HN3 
cells (p<0.001). However, KR22332 did not show any sig-
nificant protective effect on the viability of HN3 cells. The 
results indicated that KR22332 did not decrease the effect 
of radiation treatment on the cancer cells while it showed 
protective effect on the normal epithelial cell from radiation 
induced damage.
KR22332 protects against radiation-induced HaCaT 
cell apoptosis
A TUNEL assay and 4’,6-diamidino-2-phenylindole (DAPI) 
tometer (Becton Dickinson) with excitation and emission 
settings at 488 and 530 nm, respectively.
Western blot assay
Total proteins were extracted using radio immunoprecipita-
tion assay (RIPA) buffer (Sigma-Aldrich, St. Louis, MO, 
USA), following the manufacturer’s instructions. Protein 
concentrations were measured using the Bio-Rad Dc Protein 
Assay (Bio-Rad Laboratories, Hercules, CA, USA). The 
proteins were separated by electrophoresis as described pre-
viously. The following antibodies were used for Western 
blot analysis: anti-ataxia telangiectasia mutated protein 
(ATM), anti-p53 (Ser 15, 20, and 46), anti-TNF-α, anti-
cleaved caspase-3, and anti-PARP (1:1000; Cell Signaling 
Technology, Danvers, MA, USA).
Statistical analyses
Student’s t-test was used for statistical analyses of the data. 
All statistical analyses were conducted using SPSS 20.0 
statistical software (SPSS Inc., Chicago, IL, USA). Param-
eters of the data from three independent experiments are 
expressed as mean±SD. p<0.05 was considered to be sig-
nificant (*p<0.05; **p<0.01; ***p<0.001).
 
RESULTS
 
KR22332 increases HaCaT cell viability after radiation 
treatment
As shown in Fig. 2A, radiation decreased HaCaT cell via-
bility in an intensity-dependent manner. KR22332 did not 
show significant toxic effects on the cells until 10 μg/mL 
Fig. 2. Effect of KR22332 on HaCaT cell viability after radiation. HaCaT cells were exposed to various doses of radiation (0--20 Gy) or to various concentrations of 
KR22332 (0--100 μg/mL) with or without radiation (8 Gy). At 72 h after radiation, cell viability was measured by an MTT assay. (A) Radiation decreased cell viabil-
ity in an intensity-dependent manner. (B) KR22332 alone did not show significant toxic effects on the cells until 10 μg/mL. (C) Cells were pretreated with a 8 Gy 
single dose of radiation followed by treatment with 1, 10, and 50 μg/mL KR22332 for 72 h. KR22332 significantly protected HaCaT cells from radiation-induced 
cytotoxicity in a dose-dependent manner, until 10 μg/mL. The data represent mean±SD of three independent experiments. *p<0.05, **p<0.01, ***p<0.001.
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ment. Annexin V-FITC/PI staining was used to analyze the 
percentage of apoptotic cells after irradiation in the absence 
or presence of KR22332 (Fig. 4B). The number of late 
apoptotic cells is shown in the upper right quadrant; and the 
number of early apoptotic cells is plotted in the lower right 
quadrant of the histograms. We found that radiation plus 
KR22332 treatment (10 μg/mL) significantly decreased the 
number of total apoptotic cells (mean, 20.0%) compared to 
cells treated with radiation alone (mean, 37.4%; p<0.05). 
HaCaT cells treated with KR22332 alone showed no signif-
icant change in the number of Annexin V-FITC/PI-positive 
cells compared to the control. Taken together, these results 
staining were performed to determine whether radiation-in-
duced cell death in HaCaT cells occurred by apoptosis, and 
whether this cell death could be prevented by KR22332 
treatment. As shown in Fig. 4A, irradiation increased the 
number of TUNEL-positive cells while KR22332 treatment 
obviously decreased the number of TUNEL-positive cells. 
Moreover, DAPI staining revealed that KR22332 treatment 
decreased the radiation-induced nuclear condensation, 
DNA fragmentation, and perinuclear apoptotic bodies 
caused by irradiation in HaCaT cells. 
We used flow cytometry to quantify and verify the num-
ber of apoptotic HaCaT cells induced by radiation treat-
Fig. 3. Effect of KR22332 on the viability of the HNSCC cell line after treatment with radiation. (A) KR22332 did not have protective influence on the viability of 
HN3 cell. (B) HN3 cell line were pre-treated with 8 Gy single dose of radiation, followed by treatment with 1, 10, and 50 μg/mL KR22332 for 72 h. Then, cell via-
bility was measured by a MTT assay. Radiation significantly decreased cell viability on HN3 cells. KR22332 treatment did not decrease anticancer effect of 
irradiation on the cell line. The data represent mean±SD of three independent experiments. **p<0.01, ***p<0.001. NS, not significant.
Fig. 4. Effect of KR22332 on radiation-induced apoptosis in HaCaT cells. (A) Apoptosis in HaCaT cells was determined by the TUNEL method using an in situ 
cell detection kit. After monolayers achieved 60--70% confluence, the cells were exposed to radiation (8 Gy), then treated with KR22332 (10 μg/mL). The cells 
were incubated with 50 μL of TUNEL reaction mixture (TdT and fluorescein-dUTP) and stained with Hoechst 33258 (5 μg/mL). The stained cells (arrow) were 
then observed under a fluorescence microscope. The TUNEL assay confirmed that radiation induced TUNEL-positive cells (arrow), while KR22332 de-
creased the number of TUNEL-positive cells. Scale bar=50 μm. (B) To quantify the effects of KR22332 on radiation-induced apoptosis, we used flow cytome-
try; annexin V-FITC and PI staining were used to analyze the percentage of apoptotic cells in radiation-treated cells (8 Gy) in the absence or presence of 
KR22332 (10 μg/mL) (upper). The percentage of apoptosis in each fraction is expressed as a graph (lower). The data represent mean±SD of three indepen-
dent experiments.*p<0.05, ***p<0.001. DAPI, 4’,6-diamidino-2-phenylindole; TUNEL, terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end la-
beling; V-FITC, V-fluorescein isothiocynate; PI, propidium iodide.
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dependent manner. KR22332 inhibited radiation-induced 
ROS generation as much as N-acetyl-L-cysteine (NAC; 10 
mM), a potent ROS scavenger (Fig. 6). These results suggest 
that KR22332 protects HaCaT cells against radiation-in-
duced toxicity by reducing intracellular ROS formation.
KR22332 rescues HaCaT cells by inhibiting the 
caspase-3 pathway and suppressing the expression of 
ATM, p53, and TNF-α
To elucidate the underlying mechanisms of radiation-in-
demonstrate that irradiation promoted apoptotic cell death 
in HaCaT cells, but this effect was inhibited by KR22332.
KR22332 protects against radiation-induced decrease 
of MMP
The MMP can be used as an index of mitochondrial pore 
opening, which is an indicator of mitochondrial dysfunction. 
The quantitative analysis of red and green fluorescent sig-
nals from JC-1 reflects the degree of mitochondrial dam-
age. We examined the effect of radiation on the MMP in Ha-
CaT cells to determine whether the loss of MMP could play 
a role in radiation-induced apoptosis. As shown in Fig. 5A, a 
high MMP was maintained in the control cells, as indicated 
by predominantly red fluorescence of the JC-1 dye. Howev-
er, radiation treatment increased the degree of green cell fluo-
rescence, indicating a loss of MMP and mitochondrial dam-
age. KR22332 treatment (5 and 10 μg/mL) significantly 
ameliorated reduced the green fluorescence caused by irradi-
ation, and the red fluorescence was significantly restored 
(p<0.05 and p<0.05, respectively) (Fig. 5), indicating that 
KR22332 attenuated radiation-induced changes in the MMP.
KR22332 inhibits intracellular ROS generation induced 
by radiation
We next investigated the effect of radiation on the intracellu-
lar generation of ROS. Cells were treated with 8 Gy of radia-
tion, and the level of intracellular ROS was monitored by 
flow cytometry with the peroxide-sensitive fluorescent probe 
DCFDA. Irradiation significantly increased the generation of 
intracellular ROS (p<0.05). In contrast, KR22332 signifi-
cantly inhibited radiation-induced ROS generation in a dose-
Fig. 5. Effect of KR22332 on the MMP in irradiated HaCaT cells. (A) Cells were treated with KR22332 after irradiation (8 Gy) or not, stained with JC-1, and visu-
alized under a fluorescence microscope. KR22332 alone did not affect the MMP of cells. KR22332 stabilized the MMP in radiation-treated cells. (B) The 
change in the MMP was measured objectively using FACScan. The data represent mean±SD of three independent experiments. Scale bar=50 μm. *p<0.05. 
NS, not significant; MMP, mitochondrial membrane potential; FACS, fluorescence-activated cell sorting.
Fig. 6. Effect of KR22332 on radiation-induced ROS generation in HaCaT 
cells. Cells were treated with radiation (8 Gy) or KR22332 (5 μg/mL) for 72 h. 
The level of intracellular ROS was then measured by flow cytometry using 
the peroxide-sensitive fluorescent probe DCFDA. The results were calcu-
lated as a percent of the control group (not exposed to radiation). Radiation 
significantly increased the generation of intracellular ROS. KR22332 clearly 
inhibited radiation-induced intracellular ROS generation. To compare the 
inhibitory effect of a known inhibitor, 10 mM NAC was used to inhibit ROS 
generation. The data represent mean±SD of three independent experi-
ments. *p<0.05; **p<0.01. NS, not significant; ROS, reactive oxygen spe-
cies; NAC, N-acetyl-L-cysteine; DCFDA, 5-(and 6)-carboxyl-20,70-dichloro-
dihydro fluorescein diacetate.
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diotherapy often suffer from altered taste, pain, dry mouth, 
decreased appetite, and ulcers owing to OM, which results in 
a significantly decreased quality of life and prognosis.7 De-
spite many advances aimed at treating or preventing OM, the 
treatment options remain limited.8 Therefore, novel agents to 
prevent and mitigate the development of OM in patients 
during head and neck cancer treatment are clearly needed. 
In this study, we used the human keratinocyte HaCaT 
cell line as an in vitro model of the human oral mucosa to 
investigate the possible OM-protective effects of newly de-
veloped compound KR22332. Although additional cell 
populations such as fibroblasts and endothelial cells make 
up mucosal tissue, keratinocytes are among the first cells to 
encounter environmental hazards;9 human keratinocyte cul-
tures are often used to investigate the effects of ionizing ra-
diation.10 Tobita, et al.11 recently developed an in vitro mod-
el of OM using HaCaT human keratinocytes, and Donetti, 
et al.9 used human keratinocytes as an in vitro model of oral 
mucosa to study the early effects of radiation-induced OM. 
Likewise, we used HaCaT cells as an in vitro model of the 
human oral mucosa; however, a major shortcoming of our 
model is the lack of a vascular response and the influence 
of the immune system. 
Historically, the pathobiology of OM has been described 
as the indiscriminate destruction of rapidly dividing basal 
epithelial stem cells by radiation or chemotherapy. Howev-
er, the current concept is that OM results from a complex 
sequence of biological events, including the release of free 
radicals (e.g., ROS), modified proteins, and pro-inflamma-
tory cytokines (e.g., interleukin-1β, prostaglandins, and 
TNF-α) by epithelial, endothelial, and connective tissue cells, 
rather than being the direct result of clonogenic cell death.12 
KR22332 was developed recently as a novel neuroprotec-
tive drug to treat ischemic stroke, epilepsy, or exposure to 
chemical weapons such as organophospates. In fact, we 
found that KR22332 has some antioxidant properties.5 We 
demonstrated previously that radiation-induced cell death 
in human keratinocyte HaCaT cells occurred by apoptosis 
related to increased membrane damage and the generation 
of intracellular ROS.6 Therefore, we postulated that the 
novel antioxidant KR22332 could be a candidate protective 
agent for radiation-induced OM. As hypothesized, our TU-
NEL assay and Annexin-V/PI flow cytometric results re-
vealed that KR22332 prevented radiation-induced apopto-
sis in HaCaT cells. Moreover, KR22332 decreased ROS 
generation and prevented instability in the MMP, which 
were induced by irradiation, suggesting that the radiopro-
duced cell death and the protective effect of KR22332 in 
HaCaT cells, we evaluated the genes related to apoptosis 
such as cleaved caspase-3, PARP, ATM, p53 (Ser 15, 20, 
and 46), and TNF-α. As shown in Fig. 7, radiation increased 
the expression of cleaved caspase-3 and PARP cleavage, 
and KR22332 cotreatment inhibited their expression. More-
over, KR22332 inhibited the expressions of ATM, P-p53 
(Ser 15 and 46), and TNF-α, which were significantly in-
creased in cells treated with radiation only. These results 
suggest that KR22332 blocked radiation-induced apoptosis 
via down-regulation of ATM-p53 and TNF-α signaling.
DISCUSSION
OM remains one of the most common and troubling side 
effects of standard chemoradiation regimens used for the 
treatment of head and neck cancers. Patients undergoing ra-
Fig. 7. Effect of KR22332 on radiation-induced apoptosis and the phos-
phorylation of ATM-p53 and TNF-α in HaCaT cells. The cells were incubat-
ed for 72 h after treatment with/without radiation and KR22332. Cell lysates 
were collected, electrophoresed through an SDS-polyacrylamide gel, and 
subjected to Western blot analysis with antibodies against cleaved cas-
pase-3, cleaved PARP, ATM, p53, and TNF-α. KR22332 reduced the phos-
phorylation of ATM, p53 (Ser 15 and 46), and TNF-α that had been augmented 
by irradiation in HaCaT cells. TNF, tumor necrosis factor; PARP, poly (ADP-
ribose) polymerase; ATM, ataxia telangiectasia mutated; HSP, heat shock 
protein.
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signaling pathways are involved in the pathogenesis of ra-
diation-induced mucositis. In conclusion, we demonstrated 
that the novel synthetic compound KR22332 protects Ha-
CaT cells from radiation-induced damage and death by pre-
venting changes in the MMP and generation of ROS, and 
by inhibiting activation of the ATM and p53 pathways and 
TNF-α-mediated apoptotic signals. This effect was con-
firmed using an in vivo zebrafish model. HaCaT cells are an 
accepted in vitro model of oral epithelial cells; therefore, 
these findings suggest the potential of KR22332 in the re-
duction of radiation-induced OM, which is a common com-
plication of chemoradiation treatment for head and neck 
cancers.
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